
Nymox Pharmaceutical Corporation NYMX
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Nymox Pharmaceutical Corporation DPO 2011-2026 | NYMX
DPO Jährlich Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.41 K | 4.19 K | 3.12 K | 1.04 K | 1.27 K | 807 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.19 K | 807 | 2.14 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Kamada Ltd.
KMDA
|
106 | $ 8.81 | 1.73 % | $ 260 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Evogene Ltd.
EVGN
|
62.6 | $ 0.81 | -9.28 % | $ 27.9 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.79 | -1.29 % | $ 4.31 M | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
224 | $ 0.88 | -1.43 % | $ 442 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.36 | 2.27 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Codexis
CDXS
|
98.4 | $ 1.17 | -0.85 % | $ 85.9 M | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 14.49 | -0.75 % | $ 4.48 B | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M |